S. Fishbane

发表

Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.

C. Stehman-Breen, R. Kilpatrick, C. Critchlow, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Hemoglobin variability and mortality in ESRD.

M. Joffe, H. Feldman, S. Fishbane, 2007, Journal of the American Society of Nephrology : JASN.

Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies.

David W. Johnson, M. Tonelli, G. Logroscino, 2013, Kidney international.

Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.

S. Fishbane, J. Berns, Jeffrey S Berns, 2005, Kidney international.

Improvement of Hemodialysis Catheter Function with Tenecteplase: A Phase III, Open-Label Study: TROPICS 4

M. Blaney, J. Wetmore, M. Oliver, 2010, Journal of Thrombosis and Thrombolysis.

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

I. Macdougall, S. Fishbane, P. Pergola, 2013, The New England journal of medicine.

Anemia in chronic kidney disease: status of new therapies.

S. Fishbane, 2009, Current opinion in nephrology and hypertension.

Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective.

S. Fishbane, 2009, Kidney international.

Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation.

C. Kovesdy, K. Eckardt, S. Fishbane, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.

S. Fishbane, R. Wanchoo, H. Shah, 2014 .

Preservation of residual kidney function in hemodialysis patients: reviving an old concept.

K. Kalantar-Zadeh, S. Fishbane, A. Mathew, 2016, Kidney international.

Shortened Length of Stay Improves Financial Outcomes in Living Donor Kidney Transplantation

Michael Kuncewitch, G. Coppa, S. Fishbane, 2013, International Journal of Angiology.

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis

L. Szczech, S. Fishbane, R. Leong, 2020, Kidney international reports.

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

M. Chonchol, S. Fishbane, P. Pergola, 2020, Journal of the American Society of Nephrology : JASN.

Anemia in Non-Dialysis-Dependent CKD: To Treat or Not to Treat?

S. Fishbane, Daniel W. Ross, Susana Hong, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial.

W. White, F. Locatelli, S. Fishbane, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Is there an established hemoglobin target range for patients undergoing chronic dialysis?

S. Fishbane, H. Shah, 2018, Seminars in dialysis.

Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.

S. Fishbane, 2016, Seminars in nephrology.

Anaemia: FIND-CKD: intravenous iron in predialysis CKD

S. Fishbane, A. Hazzan, 2014, Nature Reviews Nephrology.

Should Target Hemoglobin Levels in Dialysis Patients be Lowered to 9–10 g/dl?

S. Fishbane, A. Hazzan, Naveed N. Masani, 2014, Seminars in dialysis.

Peginesatide for anemia in chronic kidney disease.

I. Macdougall, S. Fishbane, A. Duliege, 2013, The New England journal of medicine.

On Peginesatide and Anemia Treatment in CKD

F. Locatelli, S. Fishbane, B. Schiller, 2013 .

How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

S. Fishbane, I. Miller, S. Shirazian, 2013, Seminars in dialysis.

The New Label for Erythropoiesis Stimulating Agents: The FDA’S Sentence

S. Fishbane, K. Jhaveri, 2012, Seminars in dialysis.

The role of erythropoiesis-stimulating agents in the treatment of anemia.

S. Fishbane, 2010, The American journal of managed care.

Posttransplant anemia: the role of sirolimus.

Ajay K. Singh, S. Fishbane, A. Djamali, 2009, Kidney international.

Meeting New Challenges in the Management of Anemia of Chronic Kidney Disease Through Collaborative Care with Pharmacists

S. Fishbane, Shaffeeulah Bacchus, H. Manley, 2009, The Annals of pharmacotherapy.

Anemia and cardiovascular risk in the patient with kidney disease.

S. Fishbane, 2008, Heart failure clinics.

Editorial: The Optimal Hemoglobin in Dialysis Patients— A Critical Review

Ashutosh Kumar Singh, Ajay K. Singh, S. Fishbane, 2007, Seminars in dialysis.

Research directions: new clinical frontiers.

D. Churchill, S. Fishbane, J. Lindberg, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

S. Fishbane, M. Packman, Harini Chittineni, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

N-acetylcysteine in the prevention of contrast-induced nephropathy.

S. Fishbane, 2008, Clinical journal of the American Society of Nephrology : CJASN.

A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.

S. Fishbane, J. Maesaka, K. Marzo, 2002, Kidney international.

Regulation of renal urate excretion: a critical review.

S. Fishbane, J. Maesaka, Steven Fishbane, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients.

S. Fishbane, J. Maesaka, R. Langley, 1997, Kidney international.

Weight trends in United States living kidney donors: Analysis of the UNOS database.

S. Fishbane, E. Molmenti, Mala Sachdeva, 2015, World journal of transplantation.

Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia.

R. Bucala, B. Pereira, H. Vlassara, 1997, Kidney international.

NARRATIVE REVIEW Iron Management in Nondialysis-Dependent CKD

S. Fishbane, 2007 .

Long-term Safety of Epoetin Alfa-epbx for the Treatment of Anemia in ESKD: Pooled Analyses of Randomized and Open-label Studies

S. Fishbane, J. Wish, N. Martin, 2019, Kidney medicine.

Clinical Management of Hyperkalemia.

J. Carrero, D. Clegg, Gates B. Colbert, 2020, Mayo Clinic proceedings.

Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.

F. C. Dougherty, M. Salifu, S. Fishbane, 2007, Clinical therapeutics.

Clinician beliefs and attitudes about home haemodialysis: a multinational interview study

David W. Johnson, B. Manns, J. Craig, 2012, BMJ Open.

Self-Assessed Quality of Life in Peritoneal Dialysis Patients

S. Fishbane, J. Maesaka, E. Flaster, 2001, American Journal of Nephrology.

Treatment Target in Polycythemia Vera

I. Macdougall, S. Fishbane, A. Duliege, 2013 .

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease

K. Uhlig, G. Chertow, S. Fishbane, 2017, PloS one.

Pharmacokinetic and Pharmacodynamic Properties of Methoxy Polyethylene Glycol‐Epoetin Beta Are Unaffected by the Site of Subcutaneous Administration 1

F. C. Dougherty, B. Reigner, S. Fishbane, 2007 .

Self-assessed physical and mental function of haemodialysis patients.

S. Fishbane, J. Maesaka, E. Flaster, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Editorial Focus: Dialysis Quality and Outcomes: Quality Outcomes and Obstacles to Their Achievement in End‐Stage Renal Disease

S. Fishbane, R. Goldman, 2002 .

Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease.

S. Fishbane, W. Wisemandle, Bhupinder Singh, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Anemia treatment in chronic renal insufficiency.

S. Fishbane, 2002, Seminars in nephrology.

Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.

S. Fishbane, W. Goodman, C. Charytan, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Glomerular diseases: entering a new era.

S. Fishbane, K. Jhaveri, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)

N. Levin, S. Fishbane, J. E. Moran, 2007, The Lancet.

Iron deficiency in non-dialysis chronic kidney disease.

Ajay K. Singh, S. Fishbane, 2009, Kidney international.

Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study

A. Rastogi, C. Pollock, S. Fishbane, 2022, Journal of the American Society of Nephrology : JASN.

Course of Hyperkalemia in Patients on Hemodialysis

A. Rastogi, S. Fishbane, M. Fukagawa, 2022, International journal of nephrology.

Editorials: Recombinant Human Erythropoietin: Has Treatment Reached its Full Potential?

S. Fishbane, 2006, Seminars in dialysis.

Bone histology in patients with nephrotic syndrome and normal renal function.

S. Agarwal, S. Fishbane, S. C. Dash, 1999, Kidney international.

The evaluation of iron status in hemodialysis patients.

S. Fishbane, J. Maesaka, L. Imbriano, 1996, Journal of the American Society of Nephrology : JASN.

Anemia management in chronic kidney disease.

A. Nissenson, S. Fishbane, 2010, Kidney international. Supplement.

Iron supplementation in renal anemia.

S. Fishbane, 2006, Seminars in nephrology.

Drug Insight: safety of intravenous iron supplementation with sodium ferric gluconate complex

D. Warnock, S. Fishbane, R. Agarwal, 2006, Nature Clinical Practice Nephrology.

The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients

S. Fishbane, P. Deoreo, J. Berns, 2005, Hemodialysis international. International Symposium on Home Hemodialysis.

Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.

A. Nissenson, D. Warnock, D. Batlle, 2003, Kidney international.

Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.

A. Nissenson, D. Warnock, D. Batlle, 2002, Kidney international.

The Effect of Ktn on Nitrogen Appearance and Appetite Urea in Peritoneal Dialysis

S. Fishbane, R. Lynn, N. Ginsberg, 1995 .

Review: recombinant human erythropoietin decreases the need for blood transfusions and may delay dialysis in chronic renal failure.

S. Fishbane, 2002, ACP journal club.

Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease

S. Fishbane, W. Wisemandle, B. Spinowitz, 2019, Kidney international reports.

Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis.

S. Fishbane, K. Jhaveri, E. Lacson, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Hyponatremia in Community-Acquired Pneumonia

M. Niederman, S. Fishbane, V. Nair, 2007, American Journal of Nephrology.

Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings

Connie M. Rhee, K. Kalantar-Zadeh, J. Ingelfinger, 2022, Kidney international reports.

Cardiovascular risk evaluation before kidney transplantation.

S. Fishbane, 2005, Journal of the American Society of Nephrology : JASN.

Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review

S. Fishbane, S. Nigwekar, 2021, Kidney medicine.

Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.

S. Fishbane, R. Mehrotra, S. Sprague, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Pheochromocytoma multisystem crisis in a patient with multiple endocrine neoplasia type IIB and pyelonephritis.

S. Fishbane, V. Donovan, D. Epstein, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Comparative Safety of Intravenous Iron Dextran, Iron Saccharate, and Sodium Ferric Gluconate

S. Fishbane, S. Fishbane, E. Kowalski, 2000, Seminars in dialysis.

Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients.

S. Fishbane, J. Maesaka, E. Flaster, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of volume overload in dialysis-refractory hypertension.

S. Fishbane, J. Maesaka, E. Natke, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ferric pyrophosphate citrate for parenteral administration of maintenance iron: structure, mechanism of action, clinical efficacy and safety

T. Ganz, S. Fishbane, R. Pratt, 2022, Current medical research and opinion.

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.

Kimberly A. Walters, J. Wittes, W. Winkelmayer, 2021, The New England journal of medicine.

Dialysis: ESA responsiveness and outcomes in patients on hemodialysis

S. Fishbane, A. Hazzan, 2012, Nature Reviews Nephrology.

The Value of Intravenous Iron: Beyond the Cave of Speculation.

S. Fishbane, D. Coyne, 2020, Journal of the American Society of Nephrology : JASN.

Hemoglobin response to ferric citrate in patients with nondialysis‐dependent chronic kidney disease and iron deficiency anemia

K. Uhlig, G. Chertow, S. Fishbane, 2018, American journal of hematology.

Novel iron-based phosphate binders in patients with chronic kidney disease

S. Fishbane, H. Shah, A. Hazzan, 2015, Current opinion in nephrology and hypertension.

The effect of improved dialytic efficiency on measures of appetite in peritoneal dialysis patients

S. Fishbane, R. Lynn, N. Ginsberg, 1996 .

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

W. Winkelmayer, P. Parfrey, T. Ganz, 2022, American journal of hematology.

Serum Ferritin in Chronic Kidney Disease: Reconsidering the Upper Limit for Iron Treatment

K. Kalantar-Zadeh, A. Nissenson, S. Fishbane, 2004, Seminars in dialysis.

A randomized trial of iron deficiency testing strategies in hemodialysis patients.

S. Fishbane, W. Shapiro, P. Dutka, 2001, Kidney international.

Diagnosis of Iron Deficiency in End‐Stage Renal Disease

S. Fishbane, J. Maesaka, S. Mittal, 1999 .

Iron management in end-stage renal disease.

S. Fishbane, J. Maesaka, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

IN-DEPTH REVIEW Iron Management in End-Stage Renal Disease

S. Fishbane, J. Maesaka, 1997 .

Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells.

L. Ragolia, S. Fishbane, J. Maesaka, 2004, Kidney international.

Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study

J. Butler, P. Lavin, E. Lerma, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cerebral Salt-Wasting Syndrome: Does It Exist?

S. Fishbane, J. Maesaka, Sandeep Gupta, 1999, Nephron.

Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study.

S. Fishbane, R. Pecoits-Filho, P. Pergola, 2021, Journal of the American Society of Nephrology : JASN.

Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018.

S. Fishbane, B. Spinowitz, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.

S. Fishbane, H. Shah, A. Hazzan, 2016, Seminars in nephrology.

Intravenous iron exposure and outcomes in patients on hemodialysis.

S. Fishbane, A. Mathew, R. Wanchoo, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Inflammation and Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection

S. Fishbane, N. Uppal, H. Shah, 2020, Kidney medicine.

The emerging role of biosimilar epoetins in nephrology in the United States.

S. Fishbane, H. Shah, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Review of issues relating to iron and infection.

S. Fishbane, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Increased bone fractures among elderly United States hemodialysis patients.

S. Fishbane, K. Jhaveri, A. Mathew, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients

Ajay K. Singh, S. Fishbane, P. Fanti, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Upper Limit of Serum Ferritin: Misinterpretation of the 2006 KDOQI Anemia Guidelines

S. Fishbane, 2008, Seminars in dialysis.

Iron treatment: impact of safety issues.

S. Fishbane, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Phospholipase A2 Receptor Antibody-Positive Pregnancy: A Case Report.

S. Fishbane, I. Miller, L. Beck, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

K. Kalantar-Zadeh, A. Kliger, R. Rubin, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses

K. Uhlig, G. Chertow, S. Fishbane, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Consensus on Current Issues and Controversies in Iron Management of Patients with Chronic Renal Failure

J. Adamson, I. Cavill, S. Fishbane, 1999 .

Quality of reporting of randomization methodology in nephrology trials.

G. Strippoli, S. Fishbane, S. Shirazian, 2012, Kidney International.

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

A. Rastogi, S. Fishbane, K. Mccafferty, 2022, BMC Nephrology.

A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.

A. Rastogi, S. Fishbane, K. Mccafferty, 2019, Journal of the American Society of Nephrology : JASN.

A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.

M. Wolf, G. Chertow, S. Fishbane, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treating desmopressin-induced hyponatremia: a case using hypertonic saline.

S. Fishbane, S. Shirazian, N. Ali, 2013, Clinical nephrology.

Is there material hazard to treatment with intravenous iron?

S. Fishbane, J. Maesaka, S. Mittal, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Contribution of prostaglandin D2 synthase to progression of renal failure and dialysis dementia.

L. Ragolia, S. Fishbane, J. Maesaka, 2002, Seminars in nephrology.

Meeting the 2012 QIP (Quality Incentive Program) clinical measures: strategies for dialysis centers.

S. Fishbane, A. Hazzan, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Peginesatide in patients with anemia undergoing hemodialysis.

I. Macdougall, F. Locatelli, A. Więcek, 2013, The New England journal of medicine.

A physician's perseverance uncovers problems in a key nephrology study.

S. Fishbane, J. Wish, 2012, Kidney international.

Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.

H. Vlassara, T. Mitsuhashi, S. Fishbane, 1997, The Journal of clinical investigation.

Quality Measurement in Wonderland: The Curious Case of a Dialysis Readmissions Measure.

S. Fishbane, J. Wish, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia.

K. Uhlig, G. Chertow, S. Fishbane, 2017, Journal of the American Society of Nephrology : JASN.

Home Dialysis in the Time of COVID-19: Reflections on Rapidly Changing Policies

S. Fishbane, K. Jhaveri, Mala Sachdeva, 2020, Kidney Medicine.

COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case Series

S. Fishbane, K. Jhaveri, J. Hirsch, 2020, American Journal of Nephrology.

The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial.

S. Fishbane, Samiran Ghosh, S. Shirazian, 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Intravenous iron treatment: a comparison of available drugs

S. Fishbane, 2002 .

Beneficial effects of iron therapy in renal failure patients on hemodialysis.

S. Fishbane, J. Maesaka, S. Mittal, 1999, Kidney international. Supplement.

OP-NDTJ200160 871..883

E. Lerma, S. Fishbane, S. Ash, 2021 .

Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials

E. Lerma, S. Fishbane, S. Ash, 2020, Nephrology, Dialysis and Transplantation.

Prostaglandin D2 synthase induces apoptosis in pig kidney LLC-PK1 cells

L. Ragolia, S. Fishbane, J. Maesaka, 2001 .

Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients

F. Menzaghi, R. Spencer, M. Kashif, 2020, Kidney international reports.

Hypervitaminosis A in two hemodialysis patients.

S. Silbiger, S. Fishbane, S. Fishbane, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.

W. Winkelmayer, M. Brookhart, B. Goldstein, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Improving Detection and Management of Anemia in CKD.

S. Fishbane, S. Brunton, 2022, The Journal of family practice.

Clofarabine-induced kidney toxicity

S. Fishbane, K. Jhaveri, S. Allen, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Chapter 50 – Anemia in Patients With End-Stage Kidney Disease

S. Fishbane, H. Shah, 2017 .

Increasing Hip Fractures in Patients Receiving Hemodialysis and Peritoneal Dialysis

S. Fishbane, K. Jhaveri, A. Mathew, 2014, American Journal of Nephrology.

Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients.

S. Fishbane, G. Nassar, J. Ayus, 2002, Kidney international. Supplement.

Refractory anemia in a patient with allergy to intravenous iron drugs.

S. Fishbane, 2006, Kidney international.

Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.

S. Fishbane, J. Wagner, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

What Is Needed to Achieve a Hemoglobin of 11.0–13.0 g/dl in End-Stage Renal Disease

S. Fishbane, 2006, Blood Purification.

Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients.

M. Devita, M. F. Michelis, S. Fishbane, 2003, Clinical nephrology.

What are the Considerations in Balancing Benefits and Risks in Iron Treatment?

S. Fishbane, 2017, Seminars in dialysis.

The Role for Newly Approved Iron Treatments

S. Fishbane, 2016 .

Longitudinal predictors of uremic pruritus.

S. Fishbane, S. Shirazian, D. Moledina, 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

The surge in nephrology consultations and inpatient dialysis services during the COVID-19 pandemic.

S. Fishbane, R. Barnett, J. Hirsch, 2020, Clinical nephrology.

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.

S. Fishbane, J. Maesaka, G. Frei, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cyclical cardiorenal syndrome in late-stage kidney disease .

S. Fishbane, Benson S. Ku, 2018, Clinical nephrology.

Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients.

S. Fishbane, J. Maesaka, J. Ruggian, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment with Erythropoiesis Stimulating Agents in Patients with Chronic Kidney Disease Complicated by Cancer

S. Fishbane, K. Jhaveri, R. Wanchoo, 2017 .

Acute kidney injury in patients hospitalized with COVID-19

Kenar D. Jhaveri, Jamie S. Hirsch, Hitesh H. Shah, 2020, Kidney International.

Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.

S. Fishbane, J. Maesaka, G. Frei, 1996, Journal of the American Society of Nephrology : JASN.

KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

D. Fliser, G. Wong, S. Fishbane, 2019, Nephrology and Dialysis.

Notice

J. Adamson, J. McMurray, I. Macdougall, 2012, Kidney International Supplements.

KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease

J. Adamson, I. Macdougall, P. Parfrey, 2012 .

Partial characterization of apoptotic factor in Alzheimer plasma.

M. El-Sabban, S. Fishbane, J. Maesaka, 1999, American journal of physiology. Renal physiology.

The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?

A. Nissenson, S. Fishbane, 2007, Kidney international.

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

I. Macdougall, F. Locatelli, S. Fishbane, 2017, American Journal of Nephrology.

Update on membranoproliferative GN.

S. Fishbane, K. Jhaveri, Naveed N. Masani, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management

Janos Szebeni, Francesco Locatelli, F. Locatelli, 2014, Haematologica.

Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management

F Locatelli, J Szebeni, F. Locatelli, 2015, British journal of pharmacology.

More on renal salt wasting without cerebral disease: response to saline infusion.

S. Fishbane, J. Maesaka, L. Imbriano, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib.

S. Fishbane, K. Jhaveri, Vipulbhai Sakhiya, 2015, JAMA oncology.

Safety in iron management.

S. Fishbane, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Removal of Foley Catheters in Live Donor Kidney Transplant Recipients on Postoperative Day 1 Does Not Increase the Incidence of Urine Leaks

Michael Kuncewitch, G. Coppa, S. Fishbane, 2013, International Journal of Angiology.

Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century

N. Vaziri, S. Fishbane, G. Rostoker, 2016, Drugs.

Anemia management: a historical perspective

S. Fishbane, 2021 .

Hemoglobin variability in epoetin-treated hemodialysis patients.

S. Fishbane, P. Deoreo, J. Berns, 2003, Kidney international.

The safety of intravenous iron dextran in hemodialysis patients.

S. Fishbane, J. Maesaka, J. Wish, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection

S. Fishbane, J. Hirsch, V. Nair, 2022, American Journal of Kidney Diseases.

Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease.

T. Ganz, S. Fishbane, P. Pergola, 2019, Advances in chronic kidney disease.

Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets.

S. Fishbane, A. Besarab, 2007, Clinical journal of the American Society of Nephrology : CJASN.

A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.

W. Suki, S. Chasan-Taber, S. Moe, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment.

A. Kliger, S. Fishbane, F. Finkelstein, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review

S. Fishbane, Daniel W. Ross, K. Jhaveri, 2016, Kidney international reports.

Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure.

K. Uhlig, S. Fishbane, P. McCullough, 2018, The American journal of cardiology.

Considerations and challenges in defining optimal iron utilization in hemodialysis.

Christopher T. Chan, A. Hung, C. Kovesdy, 2015, Journal of the American Society of Nephrology : JASN.

Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

M. Joffe, H. Feldman, S. Fishbane, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administration.

F. C. Dougherty, B. Reigner, S. Fishbane, 2007, Journal of clinical pharmacology.

N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.

M. Rudnick, S. Fishbane, K. Marzo, 2004, Journal of the American Society of Nephrology : JASN.

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure.

S. Fishbane, N. Miyawaki, 2010, Kidney international.

Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury

M. Abate, P. Singhal, S. Fishbane, 2020, American Journal of Kidney Diseases.

Haplo-Storm induced acute kidney injury

S. Fishbane, K. Jhaveri, R. Bayer, 2022, Journal of Onco-Nephrology.

Tenecteplase for the improvement of blood flow rate in dysfunctional hemodialysis catheters.

M. Blaney, M. Oliver, S. Fishbane, 2010, Clinical nephrology.

Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting.

C. Kovesdy, G. Chertow, D. Charytan, 2021, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.

J. Butler, P. Lavin, E. Lerma, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Potentially Avoidable Readmissions in United States Hemodialysis Patients

K. Kalantar-Zadeh, R. Pekmezaris, S. Fishbane, 2017, Kidney international reports.

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

M. Abate, P. Singhal, S. Fishbane, 2020, Kidney International.

Introduction to unresolved issues in the care of dialysis patients

S. Fishbane, A. Mathew, 2018, Seminars in dialysis.

Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19

S. Fishbane, Sareen Shah, K. Jhaveri, 2021, Kidney International.

Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

D. Charytan, S. Fishbane, P. McCullough, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysis

S. Fishbane, K. Jhaveri, A. Mathew, 2015, Clinical transplantation.

Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program

F. Menzaghi, S. Fishbane, K. Mccafferty, 2022, Kidney medicine.

Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD

L. Szczech, S. Fishbane, P. Pergola, 2022, Kidney360.

Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia.

S. Fishbane, J. Maesaka, T. Palaia, 2007, Kidney international.

Risk for Acute Renal Failure in Patients Hospitalized for Decompensated Congestive Heart Failure

S. Fishbane, N. Miyawaki, Harini Chittineni, 2007, American Journal of Nephrology.

Managing anemia in dialysis patients: hemoglobin cycling and overshoot.

Ajay K. Singh, E. Milford, S. Fishbane, 2008, Kidney international.

The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients.

S. Fishbane, R. Lynn, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

How we treat Renal Anemia.

S. Fishbane, D. Coyne, 2020, Blood.

Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.

F. Locatelli, S. Fishbane, P. Qiu, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Changes to the end-stage renal disease quality incentive program.

S. Fishbane, I. Miller, Steven Fishbane, 2012, Kidney international.

ANEMIA , CHRONIC KIDNEY DISEASE , AND CARDIOVASCULAR DISEASE : THE CLINICAL TRIALS —

S. Fishbane, 2022 .

The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.

S. Fishbane, R. Lynn, 1995, Clinical nephrology.

Challenges and opportunities in late-stage chronic kidney disease

S. Fishbane, A. Mathew, Steven Fishbane, 2014, Clinical kidney journal.

History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients.

M. Joffe, H. Feldman, S. Fishbane, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19

S. Fishbane, J. Hirsch, 2020, American Journal of Kidney Diseases.

The Use of Iron Supplementation to Reduce ESA Dosing in Hemodialysis

S. Fishbane, I. Miller, S. Shirazian, 2013 .

Hypothesis: an erythropoietin honeymoon phase exists.

L. Szczech, S. Fishbane, N. Miyawaki, 2010, Kidney international.

Serum potassium laboratory reference ranges influence provider treatment behaviors for hyperkalemia.

S. Fishbane, K. Jhaveri, J. Hirsch, 2020, Nephrology, Dialysis and Transplantation.

Iron toxicity: relevance for dialysis patients.

N. Vaziri, S. Fishbane, A. Mathew, 2014, Nephrology, Dialysis and Transplantation.

Safety issues with iron sucrose.

S. Fishbane, 2003, American Journal of Kidney Diseases.

OP-NDTJ190312 137..150

J. Butler, P. Lavin, E. Lerma, 2020 .

Iron management in nondialysis-dependent CKD.

S. Fishbane, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients

A. Rastogi, S. Fishbane, K. Mccafferty, 2022, Kidney international reports.

Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia

A. Rastogi, S. Fishbane, K. Mccafferty, 2021, Kidney International Reports.

Adjuvant Therapies to Reduce Erythropoiesis-Stimulating Agent Dose Requirements

S. Fishbane, H. Shah, 2013 .

Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.

W. Winkelmayer, B. Pereira, S. Fishbane, 2012, Clinical nephrology.

EPO adjuvant treatments: a need for more evidence.

S. Fishbane, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System.

S. Fishbane, Daniel W. Ross, K. Jhaveri, 2016, Kidney international.

Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologists

M. Salifu, E. Lerma, S. Fishbane, 2018, BMC Nephrology.

Intravenous infusion of total dose iron in peritoneal dialysis patients: a critical appraisal.

S. Fishbane, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Avoidable Readmissions in United States Hemodialysis Patients

K. Kalantar-Zadeh, R. Pekmezaris, S. Fishbane, 2018 .

Reducing hospital readmissions in patients with end-stage kidney disease.

M. Ruospo, G. Strippoli, S. Fishbane, 2015, Kidney international.

Pruritus in chronic kidney disease

S. Fishbane, N. Uppal, A. Corona, 2022, Current opinion in nephrology and hypertension.

Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19

M. Abate, P. Singhal, S. Fishbane, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Epidemiology and Challenges to the Management of Advanced CKD.

M. Devita, S. Fishbane, A. Hazzan, 2016, Advances in chronic kidney disease.

The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study

Allison Tong, David W. Johnson, Braden Manns, 2013, BMJ Open.

Opportunities for Increasing the Rate of Preemptive Kidney Transplantation.

S. Fishbane, V. Nair, 2018, American Society of Nephrology. Clinical Journal.

S. Fishbane, H. Shah, 2019, Advances in chronic kidney disease.

‘WhatsApp®’ening in nephrology training

R. Pekmezaris, S. Fishbane, A. Kozikowski, 2019, Clinical kidney journal.

Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells.

L. Ragolia, S. Fishbane, J. Maesaka, 2001, Kidney international.

Nephrology Crossword: Onco-nephrology--chemotherapy agents and nephrotoxicity.

S. Fishbane, K. Jhaveri, 2013, Kidney international.

Methods and rationale of the DISCOVER CKD global observational study

J. Carrero, D. Wheeler, H. Heerspink, 2021, Clinical kidney journal.

A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.

S. Fishbane, H. Koncicki, 2017, Clinical journal of the American Society of Nephrology : CJASN.

How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

S. Fishbane, H. Shah, 2013, Seminars in dialysis.

Recipient Criteria Predictive of Graft Failure in Kidney Transplantation

J. Nicastro, G. Coppa, Joaquin Cagliani, 2015, International Journal of Angiology.

A phase 3b, multicenter, open-label, single-arm study of roxadustat (ASPEN): Operational learnings within United States dialysis organizations.

S. Fishbane, Amy Young, K. Cooper, 2023, Hemodialysis international. International Symposium on Home Hemodialysis.

Augmented Nurse Care Management in CKD Stages 4 to 5: A Randomized Trial.

S. Fishbane, H. Shah, L. Balsam, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Relationship Between Medication Discrepancies and Hospitalization Risk Among Patients With Advanced CKD

S. Fishbane, K. Jhaveri, Meng Zhang, 2019, Kidney international reports.

Medication discrepancies in late-stage chronic kidney disease

Meng Zhang, S. Fishbane, A. Mathew, 2017, Clinical kidney journal.

Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysis

S. Fishbane, H. Shah, 2017, Hemodialysis international. International Symposium on Home Hemodialysis.

Hypoxia-inducible factor stabilizers: 27 228 patients studied, yet a role still undefined

S. Fishbane, J. H. Ng, Deepa A. Malieckal, 2023, Clinical kidney journal.

Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis

E. Lerma, A. Rastogi, S. Fishbane, 2023, Expert review of clinical pharmacology.

Ankle-arm blood pressure index as a marker for atherosclerotic vascular diseases in hemodialysis patients.

S. Fishbane, S Fishbane, S Youn, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study

M. Jadoul, C. Herzog, B. Katona, 2023, BMJ Open.

Subgroup analyses in nephrology clinical trials.

S. Fishbane, S. Shirazian, R. Agarwal, 2012, Clinical journal of the American Society of Nephrology : CJASN.

The effect of hemodialysis ultrafiltration on changes in whole blood viscosity

D. Cho, S. Fishbane, S. Shirazian, 2012, Hemodialysis international. International Symposium on Home Hemodialysis.

The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia.

Simcha Pollack, Colleen Daly, M. Niederman, 2007, Archives of internal medicine.

Prostaglandin D2 synthase induces apoptosis in PC12 neuronal cells

L. Ragolia, S. Fishbane, J. Maesaka, 2001, Neuroreport.

Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate

H. Hirakata, T. Akiba, S. Fishbane, 2017, Kidney international reports.

Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Prospective Observational Study.

S. Fishbane, Daniel W. Ross, K. Jhaveri, 2020, Kidney360.

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD

S. Fishbane, K. Jhaveri, Meng Zhang, 2019, Kidney medicine.